Navigation Links
agents in Biological Technology

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... and in combination with approved chemotherapeutic agents versus chemotherapy alone on the frequency of ... or in combination with standard chemotherapeutic agents significantly decreases the ratio of cancer stem ... that treatment with certain chemotherapeutic agents alone may actually serve to amplify the risk for ...

Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University

... said Jeffrey Glenn. "These virus specific agents in development at Eiger possess the promise of ... on the discovery and development of new antiviral agents against novel targets for the treatment of ... includes repurposed clinical stage therapeutic agents as well as preclinical NCEs from discovery that ...

Cardinal Health Completes Biotech Acquisition

... Administration (FDA) to manufacture PET imaging agents that are used by physicians to diagnose various ... to support clinical trials of new and novel PET agents to advance the future of molecular imaging. In ... helping manufacturers expand the pipeline of new agents that will aid in the diagnosis and treatment of ...

VisEn Launches New Cat-K FAST(TM) Fluorescence Molecular Imaging Agent

... Technology") in vivo agent platform. FAST agents are based on high-performance, activatable ... . VisEn's proprietary fluorescence imaging agents and labels are designed to provide the industry's ... offers over 25 different fluorescence molecular agents for imaging key disease-associated biologic ...

Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients

... hydrochloride or any combination of these agents were eligible for enrollment and immediately ... hydrochloride or any combination of these agents were eligible for enrollment and immediately ... usually require treatment with phosphate-binding agents to lower and maintain serum phosphorus at ...

Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists

... leaders for topical agents. Use of oral agents to treat moderate and severe psoriasis declined for the second year in a row. Use of oral agents is divided primarily between methotrexate and ... biologics in the future," increased use of these agents and rapid adoption of newly approved brands may ...

VisEn Launches Next-Generation Fast ('Fluorescence Activatible Sensor Technology') Agent Platform for Expanded Performance in Imaging Disease Biomarkers In Vivo

... Newly developed by VisEn Medical, FAST imaging agents are smaller molecule, biocompatible, activatible fluorescent agents that combine increased biomarker specificity with ... new MMPSense 750 FAST , the first of the FAST agents to be launched by VisEn, was described today in a ...

New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague

... a preferred bio-weapon of terrorists. As these agents are highly dangerous all testing was done in a ... rapid confirmation of the presence of biological agents can mean the difference between life and death, ... in determining the threat posed by biologic agents will contribute to a more rapid diagnosis and ...

CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors

... effects associated with traditional cannabinoid agents can be significant. For example, cannabinoid antagonists targeting the CB1 receptor, such as agents being developed to treat obesity, have been ... RIMAs may have efficacy advantages over current agents for depression and are expected to have a good ...

Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio

... Compounds Linked to Anti-Viral agents -- TUSTIN, Calif., March 31 ... leadership in the field of phospholipid-targeting agents for the treatment of life-threatening diseases. ... of phosphatidylethanolamine (PE)-binding agents attached to a wide variety of anti-viral agents. ...

Nereus Pharmaceuticals Initiates ADVANCE, a Randomized Phase 2 Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer

... with chemotherapeutics and anti-angiogenesis agents due to the different targets and mechanisms of ... this year. About Vascular Disrupting agents (VDA) Vascular disrupting agents are a newer class ...

Quest PharmaTech Announces Results Showing its Photosensitizer, SL052, is an Effective Immuno-Stimulant when combined with Immunotherapy for the Removal of Solid Tumors

... (PDT) used in combination with immunotherapeutic agents in solid tumor animal models. The study, ... potency and effectiveness of immunotherapeutic agents when used in combination with SL052 PDT. The ... properties of activation with harmless physical agents (light and ultrasound), combined with its ability ...

ECBC's Environmental BioMonitoring Laboratory Focuses on the Future

... and detection of seven biological warfare agents utilizing robotics and high-speed ... Presumptive identification for biowarfare agents using enzyme-linked immunosorbent assays, ... Identification of bacterial agents using cell culture coupled with traditional and ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... offering both targeted therapies and oncolytic agents along with a pipeline spanning all phases ... a complementary portfolio of leading oncolytic agents and targeted therapies including GEMZAR(R), ... a setting with resuscitation equipment and other agents necessary to treat anaphylaxis (eg, epinephrine, ...

ReceptorBio Announces Diabetes License Agreement With Telik

... be co-administered with other anti-diabetic agents including insulin. The insulin ... novel class of insulin sensitizers." "The oral agents currently available on the market for the ... of action. ReceptorBio believes its novel agents are thus positioned to be first in their class, ...

Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances

... the air for virtually all of the major threat agents that could be used by terrorists. This type of ... can autonomously detect multiple types of threat agents and trigger alarms within less than a minute," ... our experiments with all these types of threat agents within minutes of each other without ...

New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients

... is not recommended. -- The use of other active agents with APTIVUS/r is associated with a greater ... to the older groups (37 percent and 31 percent). agents approved by the FDA in the past five months were ... the risk of bleeding such as antiplatelet agents and anticoagulants, or who are ...

NIST/NIH micromagnets show promise as colorful 'smart tags' for magnetic resonance imaging

... solutions now used as image-enhancing contrast agents in MRI, the NIST/NIH micro-magnets rely on a ... injectable MRI contrast agents. MRI contrast agents enhance images by altering the magnetic field ... hydrogen nuclei in water. Conventional contrast agents are chemically synthesized whereas the new ...

ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody

... and success in bringing novel anti-cancer agents to the market. This deal represents a significant ... where the therapeutic potential of anti-PlGF agents to treat cancer was first developed in the ... inhibitors such as TB-403 are therapeutic agents that work by blocking the development of new ...

Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis

... Despite the increased use of biologics, topical agents remain the most commonly prescribed therapy for ... around its formulation. While the use of oral agents to treat psoriasis increases with disease ... Dermatology setting although interest in these agents is high. About BioTrends Research Group, Inc. ...

Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent

... of therapeutic oxygen transport agents today announced that it has completed enrollment ... of Hemospan." No similar oxygen transport agents are currently on the market in Europe or the ... designed for use as therapeutic oxygen transport agents and potential alternatives to blood ...

Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights

... second-generation technetium-based imaging agents to aid in the diagnosis of PD, Dementia with ... primate studies that our technetium-based agents are effective in binding the to DAT in sufficient ... radiolabeling procedure for our technetium agents that results in a high purity, high yield product ...

Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program

... used as a prophylactic against nerve agents would add a valuable capability to the spectrum ... has been shown to bind with nerve agents to prevent lethality in in vivo challenge studies ... other classical chemical warfare agents such as vesicants, choking agents and blood ...

Peregrine Pharmaceuticals Reports Financial Results for the Third Quarter of Fiscal Year 2008

... scientific meeting on anti-angiogenic agents -- the 10th Annual International Symposium on Anti-Angiogenic agents (Angio 2008) -- highlighting the positive ... of human breast cancer. Selective anti-VEGF agents may have potential advantages over non-selective ...

FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy

... -- The use of other active antiretroviral agents with INTELENCE is associated with an ... the 47th Interscience Conference on Antimicrobial agents and Chemotherapy (ICAAC) in September 2007. ... -- Coadministration of INTELENCE with other agents such as substrates, inhibitors, or inducers ...

Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy

... in combination with the chemotherapy agents paclitaxel and carboplatin as first-line therapy ... increased by co-treatment with chemotherapeutic agents including carboplatin and taxanes such ... that was significantly greater than any of the agents alone or the combination of carboplatin and a ...

ICBS acquires 30% interest in Bacteria Bank Ltd.

... of potentially promising anti-microbial agents developed by biotech companies or researchers in ... against a wide array of Gram negative agents ( E. coli, Salmonella, shigella, and other ... the world) 4. susceptibility testing of new agents against Streptococcus pneumoniae ...

First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs

... tumors refractory to currently marketed platinum agents carboplatin, cisplatin and oxaliplatin. ... DNA cross links. About Platinum Anticancer agents Platinum agents are the most broadly used cytotoxic drugs used in ...

Oncologists Want to See Significant Improvement in Overall Survival Before Adopting Targeted Polytherapy in a First-Line Setting

... of Managed Care Organizations Fail to Cover agents with Proven Benefit for Cancer Patients, ... Forum report entitled Premium-Priced Targeted agents in Oncology: Clinician and Payer Attitudes to ... care organizations (MCOs) fail to cover both agents where two similar targeted agents are available. ...

FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections

... DORIBAX belongs to a class of antibacterial agents called carbapenems, which are important for ... life-threatening Gram-negative infections. "New agents are urgently needed to effectively treat ... reported with use of nearly all antibacterial agents and may range in severity from mild diarrhea to ...

New Data Presented on Immunocytokine Fusion Protein Further Supports Broad Anti-Cancer Potential Of Peregrine's Anti-PS Technology Platform

... agent. This new research shows that these same agents also have the potential to enhance cancer ... The new class of immunocytokine fusion protein agents is part of Peregrine's Vascular Targeting Agent ... covering broad concepts of tumor therapy using agents that target tumor blood vessels. This study, ...

EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme

... problem following high-dose radiation exposure. agents that mitigate these effects could reduce sickness ... performed by EpiStem are also likely to identify agents with oncology supportive care applications - agents that will reduce the severe ulceration and ...

Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML

... we find new effective treatment options. agents such as Cloretazine(R) (VNP40101M) have the ... innovative cancer therapeutics. Vion has two agents in clinical trials. Cloretazine(R) (VNP40101M), a ... vector used to deliver anticancer agents directly to tumors. For additional information on ...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... blocks VEGF from binding to VEGF receptor 2 (VEGFR2), while non-selective agents such as Avastin block binding to both VEGFR2 and VEGF receptor 1 (VEGFR1). Selective anti-VEGF agents such as r84 may have safety and efficacy advantages over non-selective ...

Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine

... a European patent for a novel device and methods for linking biological agents to labels for diagnostic and therapeutic applications. The technology, ... of radiolabeled anti-cancer antibodies, but is applicable to other agents as well. A study published today in the July 2009 issue of The Journal ...

Pasteuria Bioscience Receives EPA Registration for Nematode Control

... in soil that have long been recognized as promising biological control agents for plant-parasitic nematodes. "We're very pleased to receive this ... have considered Pasteuria to be among the most promising biological agents for control of plant-parasitic nematodes, but until recently, no one was ...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

... administration, CPX-351 produced prolonged half-lives for both agents and accumulation of the drugs over the three dose induction course ... allowing the release of the synergistic 5:1 molar ratio of the active agents intracellularly, and demonstrated that CPX-351 is taken up in higher ...

Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use

... novel pre-clinical and clinical-grade cellular and molecular imaging agents used to non-invasively monitor biological processes in living systems. The core innovations of the Company involve proprietary imaging agents that can be used to observe the trafficking of cells using magnetic ...

Pixantrone Significantly Increases Complete Remissions, Overall Response Rates, Frequency of Durable Remissions and Progression Free Survival in Patients with Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

... study at ASCO. "Anthracycline-related drugs can be effective salvage agents in aggressive NHL, but our use of them is limited by the significant ... treated with pixantrone than among patients who received comparator agents (8.8% vs. 4.5%). Events considered cardiac disorders included cardiac ...

Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009

... for Cisatracurium Besylate, Sinobiopharma's flagship drug, with business agents who distribute the Company's products in 30 provinces and key major cities ... China, the Company's current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs. Contacts: Sinobiopharma, Inc. ...
Other Contents
(Date:7/29/2014)... from scientists at the University of Kent has shown ... are regulated a breakthrough that could have a ... from Kent,s School of Biosciences uncovered the mechanism whereby ... known as actin filaments are ,fine-tuned, to ... filaments appear to completely stable, providing a framework for ...
(Date:7/29/2014)... new book that brings together two of the major ... profile of insect fossils through stunning photographs and unique ... James E Jepson, details the incredible preservation and diversity ... scene for what these remarkable fossils can tell us ... future of our planet. Like the mosquito in Jurassic ...
(Date:7/28/2014)... Food and Drug Administration (FDA) for other purposes can ... human cells, including those that cause Legionnaires, disease, brucellosis, ... mBio , the online open-access journal of the American ... non-antibiotic drugs that could one day help curb bacterial ... list inhibit the growth of at least three of ...
Breaking Biology News(10 mins):Unique images bring fossil insects back to life 2New route to identify drugs that can fight bacterial infections 2
(Date:7/29/2014)... Regardless of the good things that happen in ... those with. Love is about understanding, commitment and sharing ... also about overcoming all the challenges that a relationship ... women need to know how to understand guys. ... please visit the official website at http://www.dailygossip.org/enchant-him-review-7111 . ...
(Date:7/29/2014)... Daily Gossip indicates in its Acne No More ... beautiful and clear skin in just 30 to 60 days. ... results even sooner than that. The new method was created ... step by step program, too. , Mike Walden claimed ... battled this condition for a decade and none of the ...
(Date:7/29/2014)... (HealthDay News) --,The time at which heart attack patients ... survival, new research suggests. Showing up at the ... is associated with a 13 percent higher risk for ... Every year, more than 250,000 people suffer a ... heart attack, which is caused by a complete blockage ...
(Date:7/29/2014)... Advertising claims for cosmetic procedures using stem cells ... safety and effectiveness, according to a review in the ... , the official medical journal of the ... cells offer tremendous potential, but the marketplace is saturated ... patients at risk," write Dr Michael T. Longaker of ...
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Chlorine helps keep pool ... likely to develop eye infections, doctors say. ... well as blurry vision, said Dr. Sampson Davis, an ... New Jersey. It,s important to understand why this ... away the outer film layer of the eye that ...
Breaking Medicine News(10 mins):Health News:How to Reach the Heart of the Perfect Guy with "Enchant Him Program" - a Report by Daily Gossip Magazine 2Health News:Acne No More Review Reveals Most Effective Acne Cure Program 2Health News:Heart Attack Patients Treated at Night, Weekends May Have Worse Outcomes 2Health News:Beware of claims about cosmetic stem cells procedures, says review in Plastic and Reconstructive Surgery 2Health News:Protect Your Eyes When Hitting the Pool 2
Other TagsOther Tags